Global Regenerative Medicine Trainee Speaker Series
Dates: See Below Location:This series is hosted online.
The Stem Cell Network is excited to partner with five stem cell and regenerative medicine societies and networks from around the globe to profile the research achievements of outstanding trainees, including graduate students, post-doctoral fellows, and research associates in each country.
The Global Regenerative Medicine Trainee Speaker Series is a virtual event that will be held every two months to learn about cutting-edge research advances arising from the next generation of stem cell leaders in the following countries:
Each one-hour session will feature three trainee speakers nominated by their network or society representatives who will provide a 15-minute talk and a 5-minute Q&A period from the audience. Register below for the first four sessions:
Registration and Speaker Details
Session
Date
Registration
Speaker 1
Speaker 2
Speaker 3
Speaker Details
Session 1
Wednesday, July 26, 2023
7 p.m. EDT / Thursday, July 27, 2023
8 a.m. JST/KST; 9 a.m. AEST; 1 a.m. CEST
SCN - Alexander Baker, University of Toronto; "Hydrogels emulate the extracellular matrix for unbiased in vivo and in vitro organoid formation and drug testing"
JSRM - Yosuke Yoneyama, Institute of Research, Tokyo Medical and Dental University; "Modeling human fatty liver diseases with iPSC-derived organoid."
ASSCR - Osvaldo Contreras Saavedra, Victor Chang Cardiac Research Institute; "Unravelling the Effects of Thymidine Analog 5-Ethynyl-2'-Deoxyuridine on the Cell Cycle of Human Pluripotent Cells."
KSSCR - Ji-Hyun Lee, Institute for Basic Science (IBS); "p57Kip2 imposes the reserve stem cell state of gastric chief cells ."
BeSSCR - Ben van der Veer, Stem Cell Institute Leuven; "Dual functions of TET1 in germ layer lineage bifurcation distinguished by genomic context and dependence on 5-methylcytosine oxidation."
GSCN - Julia Wöstefeld, University Hospital Essen, Institute of Human Genetics; "RB1-negative organoids model retinoblastoma with proliferation of cone photoreceptors and loss of retinal cell type differentiation."
JSRM - Shogo Hashimoto, Department of Orthopaedic Surgery, Keio University School of Medicine; "Regenerative medicine strategies for chronic complete spinal cord injury."
ASSCR - Grace Lidgerwood, University of Melbourne; "Translating patient stem cells into personalised screens for age-related macular degeneration."
KSSCR - Ju-Hyun Lee, Korea Institute of Science and Technology (KIST); "Production of human spinal-cord organoids recapitulating neural-tube morphogenesis."
BeSSCR - Paraskevi Athanasouli, KU Leuven; "The Wnt/TCF7L1 transcriptional repressor axis drives primitive endoderm formation by antagonizing naive and formative pluripotency."
SCN - John Edgar, University of British Columbia; "Multi-objective optimization reveals time- and dose-dependent inflammatory cytokine-mediated regulation of human stem cell derived T-cell development."
Session:
Date:
Registration:
Speaker 1:
Speaker 2:
Speaker 3:
Speaker Details:
Eligibility
All researchers working in stem cells and regenerative medicine who are interested in learning about current work across the globe are encouraged to attend.
Conditions
By accepting a place in this seminar series, the attendee agrees to complete a survey describing the value of the training and networking opportunities made available through attending the event. This information will be used at SCN’s discretion on its website, newsletters and for the purpose of reporting to their funding agencies.
For further information on this event or for registration related enquiries, please contact Ellie Arnold at earnold@stemcellnetwork.ca.
Eligibility
All researchers working in stem cells and regenerative medicine who are interested in learning about current work across the globe are encouraged to attend.
Conditions
By accepting a place in this seminar series, the attendee agrees to complete a survey describing the value of the training and networking opportunities made available through attending the event. This information will be used at SCN’s discretion on its website, newsletters and for the purpose of reporting to their funding agencies.
Share this page
